STOCKHOLM, May 16, 2024 /PRNewswire/ -- Calliditas's
interim report for the first quarter, January - March 2024 will be published in Swedish and
English on Thursday 23 May 2024 at
07.00 a.m. CET.
A combined audio cast and telephone conference with the
opportunity to ask questions will be held at 14.30 p.m. CET on the same day, with CEO Renée
Aguiar-Lucander and CFO Fredrik
Johansson, CMO Richard Philipson and President North America
Maria Törnsén.
The presentation will be given in English.
Link to the webcast:
Calliditas Therapeutics Q1 Report 2024
(financialhearings.com)
To participate via conference call please register via this
link:
https://conference.financialhearings.com/teleconference/?id=50047214
After registration, you will receive a phone number and a
conference ID to log in to the conference call. Via the telephone
conference, there is an opportunity to ask oral questions.
For further information, please contact:
Åsa Hillsten, Head of IR & Sustainability, Calliditas
Tel. +46 76 403 35 43,
Email: asa.hillsten@calliditas.com
The information was sent for publication, through the agency
of the contact person set out above, on 16
May, 2024, at 8:30 a.m.
CET.
This information was brought to you by Cision
http://news.cision.com
https://news.cision.com/calliditas-therapeutics/r/invitation-to-the-presentation-of-calliditas-s-interim-report-january---march-2024,c3982567
The following files are available for download:
|
https://mb.cision.com/Main/16574/3982567/2801057.pdf
|
Invitation to the
presentation of Calliditas_Q1 2024
|
View original
content:https://www.prnewswire.co.uk/news-releases/invitation-to-the-presentation-of-calliditass-interim-report-january--march-2024-302147353.html